HCA Healthcare (HCA) Scheduled to Post Quarterly Earnings on Friday

HCA Healthcare (NYSE:HCA) is set to issue its quarterly earnings data before the market opens on Friday, October 25th. Analysts expect the company to announce earnings of $4.93 per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. HCA Healthcare’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same period in the previous year, the business earned $4.29 earnings per share. On average, analysts expect HCA Healthcare to post $23 EPS for the current fiscal year and $25 EPS for the next fiscal year.

HCA Healthcare Stock Up 0.5 %

HCA opened at $410.03 on Thursday. HCA Healthcare has a one year low of $215.96 and a one year high of $417.14. The company has a market cap of $107.39 billion, a price-to-earnings ratio of 20.44, a PEG ratio of 1.44 and a beta of 1.67. The business’s fifty day moving average is $394.72 and its two-hundred day moving average is $352.30. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on HCA shares. Royal Bank of Canada boosted their price target on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. Barclays upped their target price on HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research note on Wednesday, July 24th. KeyCorp initiated coverage on HCA Healthcare in a research note on Friday, October 11th. They issued an “overweight” rating and a $475.00 target price for the company. Truist Financial upped their price target on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, August 19th. Finally, Morgan Stanley initiated coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target for the company. Five research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and four have given a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $367.15.

Insider Transactions at HCA Healthcare

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the sale, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at approximately $14,569,729.80. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,345 shares of company stock worth $5,747,945. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.